Nail toxicity induced by Pemigatinib
Sign Up to like & getrecommendations! Published in 2022 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13810
Abstract: Pemigatinib is a Fibroblast grow factor receptor (FGFR) inhibitor used since 2020 as a second line in cholangiocarcinomas and advanced urothelial carcinomas. Dermatological adverse effects, like nail toxicity, have been reported in the phase 2… read more here.
Keywords: induced pemigatinib; toxicity; nail toxicity; dermatology ... See more keywords